NAAG sent a letter to the Food and Drug Administration (FDA) in response to their request for comments regarding “Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds.”
District of Columbia, Oklahoma
AK, AL, CA, CO, CT, DC, DE, GU, HI, IA, ID, IL, KY, LA, MA, MD, ME, MI, MN, MP, MS, MT, NC, ND, NE, NJ, NM, NY, OH, OK, OR, PA, RI, TN, VA, VT, WA
Connect with NAAG and the Attorney General Community
Create a NAAG account to subscribe to our newsletters or mailing lists.